How Do Anabolic Substances Work? - Episode 8: Biological Dose and the Body's Response

1. The dose on the label is not the dose that ultimately acts

In pharmacology, one of the first traps is treating the administered dose as if it were directly equal to the biological effect. It is not. Between the amount introduced into the body and the final response lie absorption, distribution, metabolism, elimination, local transformations, and interactions with biological targets. For androgens, this distance matters because testosterone and its derivatives can have different effects depending on the tissue.

That is why the idea of a biological dose is useful: it does not describe an administration recipe, but the amount of pharmacological signal that becomes effectively available to a particular biological target. Understanding this distinction helps separate pharmacokinetics from pharmacodynamics and explains why the same nominal dose does not necessarily produce the same response in two people.

2. From dose to concentration and then to effect

Pharmacokinetics follows what the body does to the substance: how much is absorbed, where it goes, how it is transformed, and how quickly it is cleared. Pharmacodynamics follows what the substance does to the body: how it interacts with targets and how those interactions become biological responses.

Between the two lies concentration at the site of action. A higher dose can increase exposure, but the relationship is not always linear. Pharmacodynamic models use concepts such as Emax and EC50 to describe the fact that an effect may increase with concentration and then approach a ceiling.

3. What does the body's response actually mean?

The response is not one single thing. For an androgen, it can include changes in lean mass, strength, erythropoiesis, lipids, reproductive function, skin, prostate, mood, or other physiological processes. Each of these responses can have a different dose-response relationship.

This is essential: there is no single effect called anabolism. The body is a network of tissues, receptors, and feedback systems. Increasing androgenic signaling can produce favorable effects in one context while also producing unfavorable effects elsewhere.

4. The dose-response curve is not an infinite staircase

In pharmacology, a dose-response curve may contain a region where small exposure increases produce visible changes, followed by a region where the response rises more slowly and, in some models, a plateau. That plateau matters because it shows that more substance does not guarantee proportionally more effect.

Real biological responses can be more complicated than an ideal curve. Receptor adaptation, endocrine feedback, metabolism, and changes caused by previous exposure can alter the response over time.

5. Emax and EC50: two concepts that explain a lot

Emax represents the maximum effect that a model can describe for a particular biological pathway. EC50 represents the concentration associated with half of that maximum effect. These are tools for describing concentration-effect relationships, not universal values that can be directly converted into a use protocol.

In a real system, two effects of the same androgen can have different Emax and EC50 values. Thus, the concentration associated with a particular muscular response should not be assumed to be the same as the concentration associated with hematological or reproductive changes.

6. Potency and efficacy are not the same thing

Potency describes how much concentration is needed to produce a given effect, whereas efficacy describes how large the response can be. Confusing the two leads to incorrect interpretations of comparisons between molecules.

A compound can have high receptor affinity and still not produce exactly the same pattern of effects as another androgen. Receptor conformation, co-regulators, and cellular context can alter how the signal is transmitted.

7. The androgen receptor is not a simple on-off switch

The androgen receptor is a nuclear protein that responds to androgenic ligands and can alter the expression of genes. But ligand binding is only the beginning. The receptor-ligand complex interacts with DNA and multiple co-regulators, and the resulting signal depends on cellular context.

That is why the same molecule should not be imagined as producing an identical effect in every tissue. Receptor biology helps explain differences between muscle, skin, prostate, nervous system, and other targets.

8. Biological dose is tissue-dependent

What matters in a tissue is not only the concentration measured in blood. Access to the cell, transport proteins, local enzymes, receptor density, and mechanisms that amplify or limit signaling all matter.

For testosterone, local conversion toward DHT or estradiol can change the biological signal. Two tissues exposed to the same plasma concentration can therefore experience different androgenic environments.

9. Why can the same dose produce different results?

Individual variability comes from several directions: age, body composition, liver and kidney function, baseline hormone levels, enzyme activity, receptor sensitivity, and overall physiological state. Even when the administered dose is identical, exposure and response can differ.

Graded testosterone studies have demonstrated this relationship: some effects on lean mass, muscle size, and strength increased with exposure, while other physiological processes had different relationships with testosterone concentration.

10. The anabolic response is not the only response

When androgens are discussed in sport, the conversation often focuses on muscle mass and strength. Pharmacology does not allow these effects to be isolated from the rest of the body. Erythropoiesis, lipid profiles, the hypothalamic-pituitary-gonadal axis, and other systems may respond at the same time.

This is one of the most important lessons of biological dose: benefit and risk can increase along different curves. There is no guarantee that a favorable effect stops exactly before unfavorable effects begin.

11. More signal does not mean infinitely more adaptation

A receptor can be activated within a system that has its own limits. Beyond a certain point, increasing concentration may produce only a small increase in the main response while exposure of other targets continues to rise.

In simple language, the body does not work like an engine in which more fuel produces the same increase in power forever. Biological systems have saturation, feedback, and costs.

12. Endocrine feedback changes the equation

Exogenous androgens can alter LH and FSH secretion through negative feedback on the hypothalamic-pituitary-gonadal axis. This means the body does not simply receive an additional signal; it may also change its own hormone production.

Therefore, the final response reflects the administered compound, endogenous production, metabolism, and feedback. It is not a simple dose-equals-effect equation.

13. Blood concentration is not the same as total exposure

A laboratory result is a snapshot. Biological exposure is a movie. Two people may have the same value on a particular morning and still have had very different concentration profiles during the preceding days.

Pharmacology also considers time spent at particular concentrations, fluctuations, metabolism, and distribution. That is why interpreting a single value without context can be misleading.

14. AUC, Cmax, and exposure time

Cmax describes the maximum observed concentration, while AUC is the area under the concentration-time curve and provides a measure of overall exposure. Tmax indicates the time at which maximum concentration is reached. These concepts help explain why two preparations containing the same nominal amount can have different pharmacokinetic profiles.

For biological effects, the shape of the curve may matter as much as an isolated value. A very high peak followed by rapid decline is not biologically identical to a more stable exposure, even when some exposure measures are comparable.

15. Metabolism can change biological dose

The body can transform an androgen into metabolites with different activities. Testosterone can be converted by aromatase to estradiol and by 5-alpha-reductase to DHT. Other metabolic pathways contribute to inactivation or generate additional androgenic metabolites.

Therefore, the biological dose of the parent molecule is not the whole story. Some effects can arise from transformation products, and these can act locally depending on the tissue.

16. Bioavailability changes the starting point

Bioavailability describes the fraction of a dose that reaches systemic circulation in a form available for action. The route of administration can change absorption and first-pass metabolism, while formulation can alter the rate at which a substance enters the body.

That is one reason why the same chemical amount should not be treated as equivalent regardless of pharmaceutical form. Pharmacokinetics determines how quickly and how much of the signal becomes available.

17. Why time matters as much as dose

The body responds to exposure unfolding over time. Some effects appear relatively quickly, while changes in gene expression, tissue remodeling, or endocrine adaptation may require longer periods.

This explains why a single laboratory measurement or one training session cannot by itself describe the cumulative effect of hormonal exposure. Pharmacodynamics has to be considered over time.

18. Acute response and chronic response

An acute response is a change occurring over a relatively short interval. A chronic response includes repeated effects and adaptations to ongoing exposure. The two are not necessarily proportional.

With repeated androgen exposure, endocrine, hematological, and metabolic changes can become part of the biological picture. Risk assessment therefore has to consider the long term, not only the immediate effect that an athlete can perceive.

19. Receptors can adapt

Biological signaling systems are not static. Prolonged ligand exposure can alter receptor expression, co-regulators, or other components of the signaling pathway. These phenomena can contribute to differences between the initial response and later responses.

This is one reason simple extrapolation from one dose to another can fail. A cell that has been repeatedly exposed is not necessarily functionally identical to the same cell before exposure.

20. Why do effects differ between individuals?

Testosterone studies have shown genuine variability in anabolic response. Even when the dose is controlled, people do not respond identically. Differences in age, body composition, baseline hormone levels, and other factors can contribute.

This variability also matters when interpreting personal stories. The fact that one person observed a particular result after a certain exposure does not demonstrate that another person will experience the same result.

21. Genetics can modify sensitivity

Genetic variation in the androgen receptor and in enzymes involved in metabolism can modify response. Genetics is not a magic explanation for every observed difference, however, and cannot be used to simply predict an individual's performance.

Modern pharmacology views response as the result of multiple variables meeting within the same biological system: molecule, exposure, receptor, tissue, metabolism, and characteristics of the individual.

22. Why two androgenic molecules should not be compared by milligrams alone

A milligram is a unit of mass, not a universal unit of biological effect. Chemical structure influences receptor affinity, metabolism, stability, distribution, and duration of exposure. Therefore, comparisons such as more milligrams equals more activity are pharmacologically simplistic.

Different molecules can produce different signaling profiles and adverse effects at exposures that cannot be directly compared by mass. This is why pharmacology does not use a single universal scale of anabolic potency.

23. Strongman and the concept of biological dose

In Strongman, the final outcome depends on much more than androgenic signaling. Strength is influenced by muscle mass, technique, coordination, nervous system function, sleep, nutrition, recovery, health, and experience. A favorable biological response in one domain does not guarantee global performance.

Athletes can also misinterpret changes in body weight or strength as direct evidence of a specific pharmacological mechanism. Without controlling training, nutrition, hydration, and recovery, causal attribution becomes difficult.

24. When performance rises, it does not mean one system alone has risen

An increase in strength can simultaneously reflect hypertrophy, neural adaptation, improved technique, changes in body mass, and altered tolerance to effort. Pharmacology may influence some of these components, but it does not automatically explain all of them.

That is why controlled studies are more informative than anecdotes. When variables are controlled, researchers can more clearly observe the relationship between exposure and effect.

25. Biological dose and risk

A higher biological dose should not automatically be interpreted as better or worse. The correct questions are what effects it increases, in which tissues, for how long, and at what biological cost. Benefits and adverse effects can follow different dose-response relationships.

With supraphysiological androgen exposure, risk cannot be separated from exposure and duration. Endocrine, hematological, and metabolic effects can occur alongside effects on muscle mass and strength.

26. What graded testosterone studies teach us

A classic study in young men used graded doses of testosterone enanthate and observed dose-dependent increases in fat-free mass, muscle size, strength, and power at certain exposure levels. At the same time, not all physiological outcomes followed the same relationship.

The scientific lesson is not a list of doses to follow. It is that different biological functions can have different dose-response curves and that human response is variable.

27. A simplified map of biological dose

The pathway can be summarized as: administered dose → absorption and bioavailability → concentration over time → distribution → tissue access → local transformation → receptor interaction → cellular signaling → physiological response → adaptation and feedback.

Each arrow can change the outcome. That is why a number expressed in milligrams is not enough to describe the biological effect of an androgen.

28. Conclusion: the body responds to the signal, not the number on the syringe

The administered dose is the starting point, not the result. Biology transforms that dose into exposure, and exposure into a set of signals that differ between tissues and individuals. Receptors, metabolism, time, and endocrine feedback determine how much of that signal becomes biologically relevant.

For Strongman, this perspective is essential. There is no simple line between more androgen and more performance. There is a network of effects, adaptations, and costs. Serious pharmacology begins precisely where we stop confusing administered dose with biological dose and perceived effect with the body's entire response.

Selected references

Bhasin S. et al. Testosterone dose-response relationships in healthy young men. American Journal of Physiology-Endocrinology and Metabolism. 2001. PubMed PMID 11701431.

Forbes GB. The effect of anabolic steroids on lean body mass: the dose response curve. Metabolism. 1985. PubMed PMID 3999979.

Pharmacodynamic principles and the time course of immediate drug effects. British Journal of Clinical Pharmacology. PMC7033401.

Wiacek M, Zubrzycki IZ. Anabolic-Androgenic Steroids Revisited: Structural Biology, Receptor Signaling, and Mechanisms of Anabolic-Androgenic Dissociation. International Journal of Molecular Sciences. 2026.